Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2024-07-02 00:00:00 ET · period of report 2024-06-28 · accession 0001415889-24-018919 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-02 | 2024-06-28 | ALXO | GARCIA PETER S | CFO | F - Tax | $6.03 | -1,789 | 122.3K | -1% | -$10.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-28 | F | D | 1,789 | $6.03 | 122,277 | D | — | — | (F2) Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024. |